Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TVTX

Travere Therapeutics, Inc.

CIK 0001438533 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$58.47
↑ 0.11 (0.19%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$5.44B
P/E Ratio
-253.82
EPS
-0.29
Dividend Yield
Not covered
52W Position
96%
Beta
1.61

Valuation multiples

Fwd P/E
76.92
PEG
Not covered
P/B
55.07
P/S
10.14
EV/Revenue
9.99
ROE
-21.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 96%
$15.03$60.10

Latest Financials

2025-12-31 FY
Revenue
$490.73M
Net Income
-$25.55M
Total Assets
$605.19M
Free Cash Flow
–

Recent news